References
Oct 1, 1977·The American Journal of Cardiology·R C HintonC M Fisher
Oct 1, 1978·Neurology·P A WolfW B Kannel
Jun 1, 1996·Annals of Internal Medicine·S D FihnR H White
Jun 4, 1999·Stroke; a Journal of Cerebral Circulation·R G HartR W Asinger
Nov 30, 1999·Annals of Internal Medicine·R G Hart, J L Halperin
Dec 28, 1999·Annals of Internal Medicine·A S GoD E Singer
Apr 13, 2000·Archives of Internal Medicine·G P SamsaJ Bian
Feb 7, 2001·Chest·J AnsellD Matchar
Feb 7, 2001·Chest·G W AlbersD E Singer
Mar 3, 2001·Thrombosis Research·M ElgD Gustafsson
Mar 3, 2001·Thrombosis Research·D GustafssonR Bylund
Mar 10, 2001·Stroke; a Journal of Cerebral Circulation·R G Hart, J L Halperin
Sep 18, 2001·Clinical Therapeutics·A J ClaxtonC Pierce
Sep 26, 2001·Archives of Internal Medicine·M CoplandR C Tait
Nov 14, 2001·Archives of Internal Medicine·J A HeitUNKNOWN AstraZeneca Arthroplasty Study Group
Mar 26, 2002·Clinical Therapeutics·Michael IskedjianA Lane Ilersich
Apr 10, 2002·Pharmacotherapy·Simon de Denus, Sarah A Spinler
Nov 2, 2002·Stroke; a Journal of Cerebral Circulation·Robert G HartLesly A Pearce
Dec 6, 2002·The New England Journal of Medicine·D G WyseUNKNOWN Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators
Dec 6, 2002·The New England Journal of Medicine·Isabelle C Van GelderUNKNOWN Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group
Feb 14, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Ulf G ErikssonDavid Gustafsson
Mar 15, 2003·Blood·Christian P KalbererAleksandra Wodnar-Filipowicz
Mar 22, 2003·Clinical Pharmacokinetics·Linda C JohanssonUlf G Eriksson
Mar 28, 2003·American Heart Journal·Stuart J Connolly
Mar 28, 2003·American Heart Journal·Ewurabena SimpsonLouise Pilote
Apr 16, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Bernd Clement, Katrin Lopian
May 13, 2003·Clinical Pharmacokinetics·Linda C JohanssonUlf G Eriksson
May 13, 2003·Clinical Pharmacokinetics·Troy C SarichUlf G Eriksson
May 13, 2003·Expert Opinion on Pharmacotherapy·Karen L Kaplan
May 14, 2003·Journal of the American College of Cardiology·Palle PetersenUNKNOWN SPORTIF II Investigators
May 14, 2003·European Journal of Clinical Pharmacology·Ulf G ErikssonDavid Gustafsson
May 21, 2003·Annals of Internal Medicine·Robert G HartUNKNOWN Stroke Prevention in Atrial Fibrillation Investigators
May 30, 2003·The Annals of Pharmacotherapy·William E Dager
Jul 8, 2003·Clinical Pharmacokinetics·Ulf G ErikssonBengt I Eriksson
Jul 8, 2003·European Journal of Clinical Pharmacology·Gunnar FagerUlf G Eriksson
Jul 9, 2003·Clinical Pharmacokinetics·Ulf G ErikssonOla Samuelsson
Jul 9, 2003·Clinical Pharmacokinetics·Karin WåhlanderUlf G Eriksson
Jul 9, 2003·Clinical Pharmacokinetics·Eva BredbergUlf G Eriksson
Jul 23, 2003·Journal of Thrombosis and Haemostasis : JTH·H ErikssonUNKNOWN Thrive Investigators
Aug 19, 2003·The Annals of Pharmacotherapy·William E Dager, Richard H White
Aug 30, 2003·American Heart Journal·Jonathan L Halperin, UNKNOWN Executive Steering Committee, SPORTIF III and V Study Investigators
Sep 5, 2003·European Journal of Clinical Pharmacology·Michael WolztUlf G Eriksson
Sep 12, 2003·The New England Journal of Medicine·Elaine M HylekDaniel E Singer
Sep 19, 2003·Lancet·Lars WallentinUNKNOWN ESTEEM Investigators
Dec 4, 2003·Lancet·S Bertil Olsson, UNKNOWN Executive Steering Committee of the SPORTIF III Investigators
Mar 18, 2004·Current Medical Research and Opinion·Kajs-Marie SchützerUlf G Eriksson
Mar 31, 2004·Journal of Clinical Pharmacology·Troy C SarichUlf G Eriksson
Apr 22, 2004·Lancet Neurology·Geoffrey A DonnanBrian R Chambers